These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19879133)

  • 1. Cell-based optimization of novel benzamides as potential antimalarial leads.
    Wu T; Nagle A; Sakata T; Henson K; Borboa R; Chen Z; Kuhen K; Plouffe D; Winzeler E; Adrian F; Tuntland T; Chang J; Simerson S; Howard S; Ek J; Isbell J; Deng X; Gray NS; Tully DC; Chatterjee AK
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6970-4. PubMed ID: 19879133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel N-(4-Piperidinyl)benzamide antimalarials with mammalian protein farnesyltransferase inhibitory activity.
    Ryckebusch A; Gilleron P; Millet R; Houssin R; Lemoine A; Pommery N; Grellier P; Sergheraert C; Hénichart JP
    Chem Pharm Bull (Tokyo); 2005 Oct; 53(10):1324-6. PubMed ID: 16204993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationship of disubstituted benzamides as a novel class of antimalarial agents.
    Mitachi K; Salinas YG; Connelly M; Jensen N; Ling T; Rivas F
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4536-9. PubMed ID: 22727641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-drug development against antioxidant enzymes from Plasmodium falciparum.
    Biot C; Dessolin J; Grellier P; Davioud-Charvet E
    Redox Rep; 2003; 8(5):280-3. PubMed ID: 14962365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminobenzosuberone derivatives as PfA-M1 inhibitors: Molecular recognition and antiplasmodial evaluation.
    Salomon E; Schmitt M; Mouray E; McEwen AG; Bounaadja L; Torchy M; Poussin-Courmontagne P; Alavi S; Tarnus C; Cavarelli J; Florent I; Albrecht S
    Bioorg Chem; 2020 May; 98():103750. PubMed ID: 32182520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
    Kohring K; Wiesner J; Altenkämper M; Sakowski J; Silber K; Hillebrecht A; Haebel P; Dahse HM; Ortmann R; Jomaa H; Klebe G; Schlitzer M
    ChemMedChem; 2008 Aug; 3(8):1217-31. PubMed ID: 18470859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, biological & cheminformatics-based assessment of N
    Toviwek B; Phuangsawai O; Konsue A; Hannongbua S; Riley J; Mutter N; Anderson M; Webster L; Hallyburton I; Read KD; Gleeson MP
    Bioorg Med Chem; 2021 Sep; 46():116348. PubMed ID: 34479064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline.
    Davioud-Charvet E; Delarue S; Biot C; Schwöbel B; Boehme CC; Müssigbrodt A; Maes L; Sergheraert C; Grellier P; Schirmer RH; Becker K
    J Med Chem; 2001 Nov; 44(24):4268-76. PubMed ID: 11708927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship and molecular modelling studies of quinazolinedione derivatives MMV665916 as potential antimalarial agent.
    Mourot L; Schmitt M; Mouray E; Spichty M; Florent I; Albrecht S
    Bioorg Med Chem; 2021 Dec; 51():116513. PubMed ID: 34798379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and SAR Evaluation of Hemozoin-Inhibiting Benzamides Active against Plasmodium falciparum.
    Wicht KJ; Combrinck JM; Smith PJ; Hunter R; Egan TJ
    J Med Chem; 2016 Jul; 59(13):6512-30. PubMed ID: 27299916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonbisphosphonate inhibitors of Plasmodium falciparum FPPS/GGPPS.
    Kabeche S; Aida J; Akther T; Ichikawa T; Ochida A; Pulkoski-Gross MJ; Smith M; Humphries PS; Yeh E
    Bioorg Med Chem Lett; 2021 Jun; 41():127978. PubMed ID: 33766764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 2-modified aristeromycins and their analogs as potent inhibitors against Plasmodium falciparum S-adenosyl-L-homocysteine hydrolase.
    Ando T; Iwata M; Zulfiqar F; Miyamoto T; Nakanishi M; Kitade Y
    Bioorg Med Chem; 2008 Apr; 16(7):3809-15. PubMed ID: 18295495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification, Characterization, and Optimization of 2,8-Disubstituted-1,5-naphthyridines as Novel Plasmodium falciparum Phosphatidylinositol-4-kinase Inhibitors with in Vivo Efficacy in a Humanized Mouse Model of Malaria.
    Kandepedu N; Gonzàlez Cabrera D; Eedubilli S; Taylor D; Brunschwig C; Gibhard L; Njoroge M; Lawrence N; Paquet T; Eyermann CJ; Spangenberg T; Basarab GS; Street LJ; Chibale K
    J Med Chem; 2018 Jul; 61(13):5692-5703. PubMed ID: 29889526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel N-branched acyclic nucleoside phosphonates as potent and selective inhibitors of human, Plasmodium falciparum and Plasmodium vivax 6-oxopurine phosphoribosyltransferases.
    Hocková D; Keough DT; Janeba Z; Wang TH; de Jersey J; Guddat LW
    J Med Chem; 2012 Jul; 55(13):6209-23. PubMed ID: 22725979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 6'-chloro-N-methyl-5'-(phenylsulfonamido)-[3,3'-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of Plasmodium.
    Liang X; Jiang Z; Huang Z; Li F; Chen C; Hu C; Wang W; Hu Z; Liu Q; Wang B; Wang L; Qi Z; Liu J; Jiang L; Liu Q
    Eur J Med Chem; 2020 Feb; 188():112012. PubMed ID: 31911293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 2-Phenoxyanilide Congeners Derived from a Hit Structure of the TCAMS: Synthesis and Evaluation of Their in Vitro Activity against Plasmodium falciparum.
    Weidner T; Nasereddin A; Preu L; Grünefeld J; Dzikowski R; Kunick C
    Molecules; 2016 Feb; 21(2):. PubMed ID: 26901174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Plasmodium falciparum Lysyl-tRNA synthetase via an anaplastic lymphoma kinase inhibitor.
    Zhou J; Huang Z; Zheng L; Hei Z; Wang Z; Yu B; Jiang L; Wang J; Fang P
    Nucleic Acids Res; 2020 Nov; 48(20):11566-11576. PubMed ID: 33053158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of Pfmrk inhibitors as potential antimalarial agents.
    Xiao Z; Waters NC; Woodard CL; Li Z; Li PK
    Bioorg Med Chem Lett; 2001 Nov; 11(21):2875-8. PubMed ID: 11597420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of inhibitors of Plasmodium falciparum N-myristoyltransferase, a promising target for antimalarial drug discovery.
    Yu Z; Brannigan JA; Moss DK; Brzozowski AM; Wilkinson AJ; Holder AA; Tate EW; Leatherbarrow RJ
    J Med Chem; 2012 Oct; 55(20):8879-90. PubMed ID: 23035716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent Plasmodium falciparum gametocytocidal compounds identified by exploring the kinase inhibitor chemical space for dual active antimalarials.
    van der Watt ME; Reader J; Churchyard A; Nondaba SH; Lauterbach SB; Niemand J; Abayomi S; van Biljon RA; Connacher JI; van Wyk RDJ; Le Manach C; Paquet T; González Cabrera D; Brunschwig C; Theron A; Lozano-Arias S; Rodrigues JFI; Herreros E; Leroy D; Duffy J; Street LJ; Chibale K; Mancama D; Coetzer TL; Birkholtz LM
    J Antimicrob Chemother; 2018 May; 73(5):1279-1290. PubMed ID: 29420756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.